A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC

Clinical trial NCT04416035 · UNKNOWN

Trial details

NCT number: NCT04416035
Sponsor: Zhejiang Teruisi Pharmaceutical Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Non-squamous Non-small-cell Lung Cancer

Start date: 2020-08-17
Primary completion: 2021-10-21
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.